Envestnet Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Buy |
29,956
+1,698
| +6% | +$61.7K | ﹤0.01% | 3236 |
|
|
2025
Q1 | $1.02M | Sell |
28,258
-6,030
| -18% | -$218K | ﹤0.01% | 3189 |
|
|
2024
Q4 | $1.44M | Sell |
34,288
-2,836
| -8% | -$119K | ﹤0.01% | 2909 |
|
|
2024
Q3 | $2.06M | Buy |
37,124
+10,584
| +40% | +$588K | ﹤0.01% | 2637 |
|
|
2024
Q2 | $1.09M | Sell |
26,540
-2,688
| -9% | -$110K | ﹤0.01% | 2976 |
|
|
2024
Q1 | $1.36M | Sell |
29,228
-308
| -1% | -$14.4K | ﹤0.01% | 2815 |
|
|
2023
Q4 | $1.41M | Sell |
29,536
-6,320
| -18% | -$302K | ﹤0.01% | 2680 |
|
|
2023
Q3 | $1.28M | Buy |
35,856
+5,675
| +19% | +$202K | ﹤0.01% | 2628 |
|
|
2023
Q2 | $1.39M | Buy |
30,181
+4,868
| +19% | +$225K | ﹤0.01% | 2514 |
|
|
2023
Q1 | $1.02M | Buy |
25,313
+1,152
| +5% | +$46.2K | ﹤0.01% | 2668 |
|
|
2022
Q4 | $1.12M | Buy |
24,161
+1,733
| +8% | +$80.3K | ﹤0.01% | 2553 |
|
|
2022
Q3 | $929K | Sell |
22,428
-1,809
| -7% | -$74.9K | ﹤0.01% | 2627 |
|
|
2022
Q2 | $1.45M | Buy |
24,237
+420
| +2% | +$25.1K | ﹤0.01% | 2323 |
|
|
2022
Q1 | $1.73M | Buy |
23,817
+3,939
| +20% | +$286K | ﹤0.01% | 2290 |
|
|
2021
Q4 | $1.67M | Buy |
19,878
+2,709
| +16% | +$228K | ﹤0.01% | 2288 |
|
|
2021
Q3 | $1.55M | Buy |
17,169
+2,404
| +16% | +$217K | ﹤0.01% | 2259 |
|
|
2021
Q2 | $1.41M | Sell |
14,765
-1,927
| -12% | -$184K | ﹤0.01% | 2302 |
|
|
2021
Q1 | $1.9M | Buy |
16,692
+7,193
| +76% | +$819K | ﹤0.01% | 1966 |
|
|
2020
Q4 | $1.32M | Buy |
9,499
+1,829
| +24% | +$253K | ﹤0.01% | 2024 |
|
|
2020
Q3 | $630K | Buy |
7,670
+2,080
| +37% | +$171K | ﹤0.01% | 2337 |
|
|
2020
Q2 | $437K | Buy |
5,590
+664
| +13% | +$51.9K | ﹤0.01% | 2486 |
|
|
2020
Q1 | $219K | Buy |
+4,926
| New | +$219K | ﹤0.01% | 2693 |
|
|
2017
Q4 | – | Sell |
-287
| Closed | -$15K | – | 2994 |
|
|
2017
Q3 | $15K | Sell |
287
-369
| -56% | -$19.3K | ﹤0.01% | 2535 |
|
|
2017
Q2 | $40K | Sell |
656
-17
| -3% | -$1.04K | ﹤0.01% | 2432 |
|
|
2017
Q1 | $46K | Buy |
673
+43
| +7% | +$2.94K | ﹤0.01% | 2445 |
|
|
2016
Q4 | $44K | Buy |
+630
| New | +$44K | ﹤0.01% | 2486 |
|